Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life

Neonatology

Volumn 94, Issue 4, 2008, Pages 267-271

  Yang, Qing ^a,b   Smith, P Brian ^a   Goldberg, Ronald N ^a   Cotten, C Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Diagnostic marker; Fecal calprotectin; Necrotizing enterocolitis; Very low birth weight infant

Indexed keywords

CALGRANULIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FECES LEVEL; FEMALE; GESTATIONAL AGE; HEMATOCHEZIA; HUMAN; INFANT; INFANT FEEDING; INFANT NUTRITION; INTESTINE PERFORATION; MALE; NECROTIZING ENTEROCOLITIS; PERINATAL PERIOD; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

ENTEROCOLITIS, NECROTIZING; FECES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 51249094899     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000151645     Document Type: Article

References (22)

1. Henry MC, Moss RL: Current issues in the management of necrotizing enterocolitis. Semin Perinatol 2004;28:221-233.
2. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL and the NICHD Neonatal Research Network: Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991;119:630-638.
3. Network TCN: Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr 2004;39:366-372.
4. Dale I, Brandtzaeg P, Fagerhol MK, Scott H: Distribution of a new myelomoncytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985;84:24-34.
5. Roseth AG, Schmidt PN, Fagerhol MK: Correlation between faecal excretion of 111-indium labeled granulocytes and calprotectin, a granulocyte marker protein in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50-54.
6. Roseth AG, Aadland E, Jahnsen J, Raknerud N: Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176-180.
7. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, Scalici C, Montalto G, Di Fede G, Rini GB, Notarbartolo A, Averna MR: Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem 2003;49:861-867.
8. Olafsdottir E, Aksnes L, Fluge G, Bersad A: Faecal calprotein levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50.
9. Rugtveit J, Fagerhol MK: Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002;34:323-324.
10. Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N: High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F353-F355.
11. Nissen AC, van Gils CE, Menheere PP, Van den N, Anita M, van der Hoeven MA, Forget PP: Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004;38:107-108.
12. Josefsson S, Bunn SK, Domellöf M: Fecal calprotectin in very low birth weight infants. J Pediat Gastroenterol Nutr 2007;44:407-413.
13. Laforgia N, Baldassarre ME, Pontrelli G, Indrio F, Altomare MA, Di Bitonto G, Mautone A: Calprotectin levels in meconium. Acta Pediatr 2003;92:463-466.
14. Carroll D, Corfield A, Spicer R, Cairns P: Fecal calprotectin concentrations and diagnosis of necrotizing enterocolitis. Lancet 2003;361:310-311.
15. Weaver LT, Laker MF, Nelson R: Intestinal permeability in the newborn. Arch Dis Child 1984;59:236-241.
16. Cummins AG, Thompson FM: Postnatal changes in mucosa immune response: a physiological perspective of breastfeeding and weaning. Immunol Cell Biol 1997;75:419-429.
17. Berseth CL, Nordyke C: Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants. Am J Physiol 1993;264:G1046-G1051.
18. Shulman RJ, Schanler RJ, Lau C, Heitkemper M, Ou CN, Smith EO: Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr 1998;133:645-649.
19. Sangild PT: Gut responses to enteral nutrition in preterm infants and animals. Exp Biol Med 2006;231:1695-1711.
20. Lucas A, Bloom SR, Aynsley-Green A: Gut hormones and 'minimal enteral feeding'. Acta Paediatr Scand 1986;75:719-723.
21. Berseth CL: Minimal enteral feedings. Clin Perinatal 1995;22:195-205.
22. Tøn H, Brandsnes Ø, Dale S, Holtlund J, Skuibina E, Schjønsby H, Johne B: Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41-54.